M-M-R II

M-M-R II Drug Interactions

measles, mumps and rubella vaccine

Manufacturer:

Distributor:

Zuellig

Concise Prescribing Info Full Prescribing Info Contents Description Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Side Effects Drug Interactions Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Full Prescribing Info

Drug Interactions

Administration of immune globulins concurrently with MEASLES, MUMPS, AND RUBELLA VIRUS VACCINE LIVE (M-M-R II) may interfere with the expected immune response. Vaccination should be deferred for 3 months or longer following administration of immune globulin (human) and blood or plasma transfusions.

Continue with Google

Already a member? Sign in

M-M-R II Drug Interactions

measles, mumps and rubella vaccine

Manufacturer:

Merck Sharp & Dohme

Distributor:

Zuellig